E-ISSN: 1308-5263
Thromboembolism in Patients with Cancer [Turk J Hematol]
Turk J Hematol. 2004; 21(1): 0-0

Thromboembolism in Patients with Cancer

Abdullah Büyükçelik, Hakan Akbulut
Department Of Medical Oncology, Ankara University Medical Faculty, İbn-i Sina Hospital,ankara

One hundred and forty years ago, Armand Trousseau described phlegmasia alba dolens as a sign of internal malignancy. Nowadays, it is commonly believed that the presence malignant tumaor increases the risk of venous thromboembolism (i.e deep vein thrombosis and pulmonary embolism) However, cancer is usually associated with other factors such as old age, extensive surgery,immobility, etc., which may predispose to thromboembolism. The majority of thrombotic events occur in the venous system; the incidence of arterial thrombosis is much lower.Recurrent thromboembolism in cancer patients frequently and diminishes the quality of life of the patients.Furthermore, if the thromboembolism is massive, destipte of early and aggressive treatment, it may result in death. In this article, we review thromboembolic complications in cancer patients.

Keywords: thromboembolism, cancer, prevention, heparin, low-molecular-weight, anticoagulant, treatment

Abdullah Büyükçelik, Hakan Akbulut. Thromboembolism in Patients with Cancer. Turk J Hematol. 2004; 21(1): 0-0

Corresponding Author: Abdullah Büyükçelik, Türkiye

Download citation
Reference Manager
Share with email
Send email to author

Similar articles
Google Scholar


Impact Factor (2020) = 1.831